Technical Analysis for DYAI - Dyadic International, Inc.

Grade Last Price % Change Price Change
grade C 4.82 7.11% 0.32
DYAI closed up 7.11 percent on Monday, March 30, 2020, on 1.4 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical DYAI trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 7.11%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.11%
Calm After Storm Range Contraction 7.11%
Inside Day Range Contraction 7.11%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (such as virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Additionally, and more recently, Dyadic is also beginning to explore the use of its C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of Adeno-associated viral vectors (AAV) and certain metabolites. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers and, hopefully, improve access and cost to patients and the healthcare system, but most importantly save lives.
Biotechnology Biopharmaceutical Manufacturing Life Sciences Pharmaceutical Industry Natural Sciences Medication Pharmacy Antibodies Gene Expression Vaccine Biopharmaceuticals Biosimilar Fusion Protein Healthcare System Virus Like Particle

Is DYAI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.0
52 Week Low 2.51
Average Volume 310,811
200-Day Moving Average 5.75
50-Day Moving Average 5.24
20-Day Moving Average 4.47
10-Day Moving Average 4.04
Average True Range 0.74
ADX 19.6
+DI 29.48
-DI 17.70
Chandelier Exit (Long, 3 ATRs ) 5.79
Chandelier Exit (Short, 3 ATRs ) 4.72
Upper Bollinger Band 6.12
Lower Bollinger Band 2.83
Percent B (%b) 0.61
BandWidth 73.61
MACD Line -0.27
MACD Signal Line -0.38
MACD Histogram 0.1173
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.86
Resistance 3 (R3) 5.88 5.57 5.68
Resistance 2 (R2) 5.57 5.30 5.55 5.62
Resistance 1 (R1) 5.19 5.14 5.38 5.17 5.57
Pivot Point 4.88 4.88 4.97 4.86 4.88
Support 1 (S1) 4.50 4.61 4.69 4.48 4.07
Support 2 (S2) 4.19 4.45 4.17 4.02
Support 3 (S3) 3.81 4.19 3.96
Support 4 (S4) 3.79